Menu
Previous
Next
BLB is a contract research organization
that aims to contribute with pharmaceutical partners to ultimately
accelerate the development of
new treatments for patients with liver disease
Company
BLB is a contract research organization that aims to contribute with pharmaceutical partners to ultimately accelerate the development of new treatments for patients with liver disease. BLB was created in 2017 by KOL in the field of liver disease research and management from the Hospital Clinic Barcelona & IDIBAPS.
The virtuous combination of having deep experience in both pre-clinical and clinical phases of liver research permits BLB to provide key strategic consultancy to our partners. We aim at accelerating the development of new biopharmaceutical compounds, being helpful at any stage of their development: from the very beginning of your pipeline to the design and execution of phase 3 trials.
Vision & Mission
BLB aims at providing superior quality research services and consulting in the fields of Hepatology. We combine exclusive cutting-edge technology with reliable traditional models that altogether permits high-value characterization of new chemical entities.
In BLB we truly believe that refinement of pre-clinical research, by using smarter experimental models that closer reflect patients’ pathophysiology, is the only way to shorten the bridge between bench work and clinical practice.
We are supported by the Clínic Barcelona - IDIBAPS Biomedical Research Institute & the CaixaImpulse bio-entrepreneurship program, allowing us to grow within an environment of excellence in business & innovation.
Our Values
We are innovative, passionate
and scientificall y curious
We prioritize rigorousness and integrity
We listen our customers, so we provide the best solution for their enquiries
We are committed with our community & the environment